|
Previous: NPS PHARMACEUTICALS INC, S-3, EX-5.1, 2000-07-19 |
Next: GOVERNMENT SECURITIES INC FD GNMA SER 1V DEFINED ASSET FDS, 485BPOS, 2000-07-19 |
<PAGE> EXHIBIT 23.1 Consent of Independent Certified Public Accountants The Board of Directors NPS Pharmaceuticals, Inc.: We consent to the use of our report incorporated herein by reference and to the reference to our firm under the heading "Experts" in the prospectus. /s/ KPMG LLP Salt Lake City, Utah July 17, 2000
|